A meta-analysis of extended versus standard lymphadenectomy in patients undergoing pancreatoduodenectomy for pancreatic adenocarcinoma.
BACKGROUND
Lymph node involvement in pancreatic adenocarcinoma is a key prognostic factor. Therefore, extending the number of lymph node stations excised in pancreatoduodenectomy may be beneficial to patients with pancreatic adenocarcinoma. This systematic review and meta-analysis examines the outcomes of extended versus standard lymphadenectomy in the published literature.


METHODS
A meta-analysis of randomized controlled trials (RCTs) comparing extended with standard lymphadenectomy in patients undergoing pancreatoduodenectomy for pancreatic adenocarcinoma was performed. Perioperative outcomes were assessed as pooled odds ratios (ORs) and weighted mean differences. Overall survival was analysed for patients with positive and negative lymph nodes. Results were reported according to the PRISMA statement.


RESULTS
Five RCTs were included, accounting for 724 patients. Extended lymphadenectomy was associated with greater operative time [mean difference: 63 min, 95% confidence interval (CI) 29-96; P < 0.001], increased need for blood transfusions (mean difference: 0.20, 95% CI 0.01-0.30; P = 0.030) and greater postoperative morbidity (OR 1.5, 95% CI 1.25-2.00; P = 0.030), as well as with prolonged diarrhoea after circumferential autonomic nerve dissection around major vessels (OR 12.2, 95% CI 5.3-28.5; P < 0.001). Median survival was similar across the groups in the whole cohort, as well as in subgroups of patients with, respectively, positive and negative lymph nodes.


CONCLUSIONS
Extended lymphadenectomy has a harmful impact on patients undergoing oncological pancreatoduodenectomy compared with standard lymphadenectomy.
Division of Abdominal Surgery, Department of Surgery, Faculty of Medicine, University of Geneva, Geneva, Switzerland.|Hepato-Pancreato-Biliary Centre, Geneva University Hospitals, Geneva, Switzerland.
Lorenzo A
LA
Orci
Division of Abdominal Surgery, Department of Surgery, Faculty of Medicine, University of Geneva, Geneva, Switzerland.|Hepato-Pancreato-Biliary Centre, Geneva University Hospitals, Geneva, Switzerland.
Jeremy
J
Meyer
Division of Clinical Epidemiology, Department of Health and Community Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.|Centre de Recherche Clinique, Geneva University Hospitals, Geneva, Switzerland.
Christophe
C
Combescure
Division of Abdominal Surgery, Department of Surgery, Faculty of Medicine, University of Geneva, Geneva, Switzerland.|Hepato-Pancreato-Biliary Centre, Geneva University Hospitals, Geneva, Switzerland.
Leo
L
Bühler
Division of Abdominal Surgery, Department of Surgery, Faculty of Medicine, University of Geneva, Geneva, Switzerland.|Hepato-Pancreato-Biliary Centre, Geneva University Hospitals, Geneva, Switzerland.
Thierry
T
Berney
Division of Abdominal Surgery, Department of Surgery, Faculty of Medicine, University of Geneva, Geneva, Switzerland.|Hepato-Pancreato-Biliary Centre, Geneva University Hospitals, Geneva, Switzerland.
Philippe
P
Morel
Division of Abdominal Surgery, Department of Surgery, Faculty of Medicine, University of Geneva, Geneva, Switzerland.|Hepato-Pancreato-Biliary Centre, Geneva University Hospitals, Geneva, Switzerland.
Christian
C
Toso
D000230:Adenocarcinoma / Q000401:mortality / Q000556:secondary / Q000601:surgery*; D001803:Blood Transfusion; D006801:Humans; D008197:Lymph Node Excision / Q000009:adverse effects / Q000379:methods* / Q000401:mortality; D008207:Lymphatic Metastasis; D016017:Odds Ratio; D061646:Operative Time; D010190:Pancreatic Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D016577:Pancreaticoduodenectomy / Q000009:adverse effects / Q000401:mortality; D011183:Postoperative Complications / Q000209:etiology; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D016019:Survival Analysis; D013997:Time Factors; D016896:Treatment Outcome